Home
Mailbox
Boards
Favorites
Whats Hot!
Login - Join Now!
Search
Search Type
Board
Post
Member
CytoDyn Inc CYDY
Board Mod:
HHIGambler
Asst Mods:
Evil Rabbit
CaptnAmerca
mightycydy
Last Post: 10/30/2025 5:19:16 PM
Board Marks: 394
Posts Today: 0
Board Views Today: 2138
CytoDyn Inc CYDY
CytoDyn Inc. (OTCQB: CYDY)
Company Website:
http://www.cytodyn.com/
CYDY Company Profile
CYDY Time & Sales
CYDY Recent News
CYDY Filings
CYDY Financials
CYDY Buy Rating
sean007
08/01/2025 9:20:49 PM
Our lease on Main St. ends April
(3)
Evil Rabbit
08/01/2025 8:49:12 PM
Thanks Wax. Ive been out all day so
(8)
misiu143
08/01/2025 2:19:35 PM
She has stage 4 Malignant Melanoma ,
(12)
sean007
08/01/2025 1:01:10 PM
They are making funeral plans...what a
(4)
sean007
08/01/2025 12:59:33 PM
John Mellencamps daughter Teddi
(1)
waxonwaxoff
08/01/2025 12:44:33 PM
Thanks Gambler. Truly an exercise in
(11)
HHIGambler
08/01/2025 12:37:15 PM
On behalf of the IHang team and those
(14)
waxonwaxoff
08/01/2025 12:27:10 PM
Banned from r/Livimmune last night
(3)
cardamine
07/31/2025 8:55:33 PM
(I did NOT mean an emoji! I meant to
(4)
cardamine
07/31/2025 7:52:12 PM
(fwiw: "While specific adverse event
(3)
Figgs
07/31/2025 2:27:06 PM
Could Leronlimab be used as a longevity
(5)
Evil Rabbit
07/31/2025 1:18:01 PM
Hey Riz (NOMOD), Youve been told by
(26)
dfwl28
07/31/2025 12:46:45 PM
IL-6 cytokine -slow day "...Unlike
enemyofpluto
07/30/2025 8:55:53 PM
1,750 million IS 1.75B.
(7)
bbqbbq
07/30/2025 7:23:49 PM
Garry Nolan's role with the CCR5
(6)
misiu143
07/30/2025 3:54:40 PM
It is not always easy , her doctor in a
(8)
ohm20
07/30/2025 3:48:55 PM
Dr Jay do not give RTT or
(11)
misiu143
07/30/2025 3:34:38 PM
Not always that easy to get IRB. Friend
(5)
sean007
07/30/2025 3:29:10 PM
The FDA approves over 99% of ALL
(12)
misiu143
07/30/2025 2:00:30 PM
Dr Jay do not give RTT or
(16)
NOMOD
07/30/2025 9:10:47 AM
Youre very welcome. Youre doing
(7)
cardamine
07/30/2025 1:30:00 AM
Thank you for writing all this out--it
(3)
NOMOD
07/30/2025 1:08:21 AM
I cant PM, so feel free to email me
(20)
cardamine
07/30/2025 12:50:56 AM
Quick Question re right to
(5)
sjacobs26
07/29/2025 4:37:59 PM
Just doing a quick comparisonCELC
(21)
cardamine
07/29/2025 3:23:29 PM
still as of yesterday, only approx 12
MidnightRider
07/29/2025 3:17:38 PM
From Reddit yesterday : r/Livimmune
(8)
Katangolo
07/29/2025 11:45:29 AM
Yes, mitochondrial dysfunction, Golgi
(2)
Katangolo
07/29/2025 11:44:14 AM
Amen. Youre dialed
(4)
Katangolo
07/29/2025 11:42:55 AM
Crp, iL-6, pd1 anything involved in
(8)
craigakess
07/29/2025 10:27:19 AM
I think you might mean 1.75 billion
(2)
MIM-104
07/29/2025 7:20:17 AM
You can read this in detail via this
(3)
docj
07/29/2025 7:11:27 AM
1,750 million authorized shares of
(2)
ohm20
07/29/2025 1:31:17 AM
IHUB is currently under federal watch
(16)
ohm20
07/29/2025 1:22:34 AM
There is one obvious bio-marker, or end
(20)
Figgs
07/28/2025 10:59:35 PM
Took long weekend to Canada. Nice
(2)
My69z
07/28/2025 10:43:02 PM
Deals for Phase 1 have brought $1b+.
(10)
JmcII
07/28/2025 10:19:04 PM
Does anyone know our total shares
sunray3
07/28/2025 7:32:47 PM
I'm sure you're right, there are going
Mr3Putt
07/28/2025 7:25:01 PM
2025-07-24 * Study Status * Arms and
(1)
Evil Rabbit
07/28/2025 7:16:25 PM
Clinictrials.gov is always late to be
(2)
Buddyboy20
07/28/2025 6:52:03 PM
Two study locations?
(1)
Mr3Putt
07/28/2025 6:40:22 PM
updates posted to CRC trial:
(7)
sherlock57
07/28/2025 4:46:46 PM
"Since we are doing a clinical trial,
(12)
sunray3
07/28/2025 12:02:02 PM
If so (not doubting you) then not
(8)
Buddyboy20
07/28/2025 11:25:09 AM
I can almost guarantee that his
(2)
sunray3
07/28/2025 11:18:19 AM
Thanks for the update on Dr C's
(7)
Buddyboy20
07/28/2025 10:00:14 AM
It has been over one year that Dr Chan
(22)
Mr3Putt
07/28/2025 9:48:14 AM
Your question is answered precisely
(2)
SaltyMutt
07/28/2025 7:51:21 AM
Does this one fly soon?
(1)
Newer
Older
Recent Articles
Chevron Prepares to Announce Q3 Financial Results Soon
Exciting Tesla Cybercab Prototype: Steering Wheel Surfaces
China Leads the Way in Urban Health amidst Climate Challenges
Zoomlion's Vision for Sustainable Smart Cities Worldwide
Crédit Agricole S.A. Completes Share Repurchase Program Successfully
Fresnillo Makes Strategic Move to Acquire Probe Gold
Projected Growth of Genomics Data Analysis Market to 2034
Nanobiotix Secures Up to $71 Million in Innovative Funding
Exciting Launch of $PRDT Token Promises Revenue Sharing Rewards
Michael Burry's Caution: Avoiding Market Bubbles in 2025
Rep. Marjorie Taylor Greene Increases Investment in Tech Stocks
AB Artea Bankas Receives Updated Capital Requirements from ECB
Mohamed El-Erian Analyzes AI Market: Cautiously Optimistic
Bekaert's Share Buyback Program and Liquidity Actions Explained
Sidetrade Partners with NX to Enhance CFO Agility and Growth
Top Stock Performers: Insights on Major Market Movers
Facephi Shows Strong Financial Performance and Future Growth
Kalmar Reports Strong Q3 2025: Profitability and Success in Services
Loomis Achieves Remarkable Performance in Recent Quarter
Analyzing Investor Sentiment: Nasdaq's Recent Performance Trends
Exxon Mobil's Q3 Earnings Preview: Analyst Predictions and Insights
DXS International's Annual Report: Key Insights and Financials
Digitalist Group's Third Quarter Review Highlights 2025 Results
Strong Q3 Results Highlight Growth and Stability for WEHB
NB Private Equity Partners Effectively Executes Share Buyback
ICG Enterprise Trust plc Makes Strategic Share Buyback Move
Understanding the Voting Rights of Northern Venture Trust PLC
Nanobiotix Partners with Healthcare Royalty for $71 Million Deal
Fresnillo Enters Agreement to Purchase Probe Gold for C$780M
Understanding Voting Rights at Northern 2 VCT PLC
Notable Growth for INVL Technology in 2025 Financials
Understanding the Latest Net Asset Value of INVL Technology
Nxera Pharma's Vision Unveiled at Upcoming London Healthcare Conference
Bioretec Ltd Adjusts H1 Report: Financial Highlights and Outlook
Tetragon Financial Group Reveals September 2025 Insights
Bioretec Ltd Updates Financial Report Details for 2025
Loomis Reports Robust Performance in Q3 2025 with Growth
Investments from Optiver and Qube Strengthen McKay Brothers
Strategic Investments by Optiver and QRT Propel McKay Brothers
Mycenax Partners with RIN Institute to Transform ADC Technology
Transforming Enterprises: FastGPT's No-code AI Solutions for 2025
Corbus Pharmaceuticals Moves Forward with Public Offering
S&P 500 Achieves Historic Winning Streak and Market Insights
Key Challenges Highlighted by Michael Saylor for Growth Strategy
Ecer.com Launches Innovative AI Marketplace Strategy for Trade
Bioretec Ltd Revises 2025 Half-Year Report with Key Updates
DigitalXForce Achieves Prestigious Leader Status in IDC Assessment
Danske Bank Sees Positive Trends and Growth for 2025
Sampo plc's Latest Share Buyback Program and Results
Exciting Developments in Kudu Well Appraisal by BW Energy